Drug interactions at the moment are the best obstacle in treating HIV/HCV co-contaminated clients. When it comes to safety outcomes, tenofovir DF used with ledipasvir or velpatasvir can result in a rise in serum creatinine, notably when coupled with a pharmacokinetic booster. [139] Using tenofovir D